Source: Annual Congress 2001 - Inflammation, infection and exercise capacity in cystic fibrosis patients



Rating:

Share or cite this content

Citations should be made in the following way:
S. Schmitt-Grohe, C. Naujoks, R. Schubert, J. Bargon, T. O. Wagner, S. Zielen (Bonn, Frankfurt, Germany). Cytokine production in whole blood and disease severity in cystic fibrosis. Eur Respir J 2001; 16: Suppl. 31, 853

Member's Comments

No comment yet.

Related content which might interest you: Disturbance of pro-inflammatory cytokine production in patients with cystic fibrosis lung disease Source: Eur Respir J 2005; 26: Suppl. 49, 404s Year: 2005 Aspergillus-induced superoxide production by cystic fibrosis phagocytes is associated with disease severity Source: ERJ Open Res, 4 (2) 00068-2017; 10.1183/23120541.00068-2017 Year: 2018 Elastase activity on sputum neutrophils correlates with severity of lung disease in cystic fibrosis Source: Eur Respir J, 51 (3) 1701910; 10.1183/13993003.01910-2017 Year: 2018 Sputum glucose as a marker of disease severity in adult patients with cystic fibrosis Source: International Congress 2018 – Cystic fibrosis in adults: current research Year: 2018 Arginase in patients with cystic fibrosis airway disease Source: Annual Congress 2004 - Cystic fibrosis in the 21st century: cutting edge investigations, taxing problems Year: 2004 Increased CCL18 production in interstitial lung diseases is associated with fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 38s Year: 2004 Circulating inflammatory cytokines in adult cystic fibrosis patients Source: Annual Congress 2009 - Cystic fibrosis: advances in clinical research Year: 2009 Increased CCL18 serum levels in patients with pulmonary fibrosis which reflect disease severity Source: Eur Respir J 2005; 26: Suppl. 49, 21s Year: 2005 Decreased expression of HLA-DQ and -DR on blood monocytes, sputum macrophages and monocyte-derived macrophages in patients with cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology Year: 2014 Inflammatory markers can predict pulmonary exacerbations of cystic fibrosis Source: International Congress 2017 – Cystic fibrosis: monitoring and biomarkers Year: 2017 Fibulin-1 is a novel biomarker of disease severity in pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 Pathophysiology of cystic fibrosis lung disease Source: Eur Respir Monogr 2014; 64: 1-13 Year: 2014 Biomarkers of early relapse of pulmonary exacerbation in cystic fibrosis adult patients Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 Season dynamics of inflammatory markers in patients with cystic fibrosis lung disease Source: Eur Respir J 2002; 20: Suppl. 38, 528s Year: 2002 The cytokine interleukin-17 is raised in the airway of people with cystic fibrosis Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease Year: 2009 Serum exosomes from IPF patients display a fibrotic miRNA profile that correlates to clinical measures of disease severity Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 The RANKL-OPG balance in pulmonary fibrosis Source: International Congress 2015 – Connective tissue disorders Year: 2015 Circulating monocytes from interstitial lung disease patients show an activated phenotype Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Role of interleukin-10 in idiopathic pulmonary fibrosis Source: Eur Respir J 2004; 23: 179-180 Year: 2004 Serum progranulin levels in idiopathic pulmonary fibrosis and other interstitial lung diseases Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF) Year: 2018